- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
PETNET allies with academia
CTI Molecular Imaging subsidiary PETNET Solutions is partnering with Johns Hopkins Healthcare to manage production and distribution of clinical PET radiopharmaceuticals produced at the existing Hopkins PET cyclotron production facility. The agreement
CTI Molecular Imaging subsidiary PETNET Solutions is partnering with Johns Hopkins Healthcare to manage production and distribution of clinical PET radiopharmaceuticals produced at the existing Hopkins PET cyclotron production facility. The agreement calls for PETNET to manage the production facility and supply PET isotopes to the surrounding market, as well as help support some of Hopkins' PET clinical and research programs.
PETNET has also agreed to collaborate with the Yerkes National Primate Research Center of Emory University in the research and development of new PET molecular probes. The two will operate a preclinical research site at Yerkes' new neuroscience building, scheduled to open this fall. PETNET also plans to establish a production facility at Yerkes to supply PET isotopes for clinical and research needs, including those at the center.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
MRI-Based AI Model Shows Promise in Predicting Lymph Node Metastasis with Breast Cancer
April 15th 2024For the prediction of axillary lymph node metastasis in patients with breast cancer, an MRI-based, 4D convolutional neural network model demonstrated an AUC of 87 percent and sensitivity of 89 percent, according to new research.
